Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle

Abstract Radiotherapy (RT) has been viewed as one of the most effective and extensively applied curatives in clinical cancer therapy. However, the radioresistance of tumor severely discounts the radiotherapy outcomes. Here, an innovative supramolecular radiotherapy strategy, based on the complexatio...

Full description

Bibliographic Details
Main Authors: Xiaoxue Hou, Yu‐Xuan Chang, Yu‐Xin Yue, Ze‐Han Wang, Fei Ding, Zhi‐Hao Li, Hua‐Bin Li, Yicheng Xu, Xianglei Kong, Fan Huang, Dong‐Sheng Guo, Jianfeng Liu
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202104349
_version_ 1819289963519279104
author Xiaoxue Hou
Yu‐Xuan Chang
Yu‐Xin Yue
Ze‐Han Wang
Fei Ding
Zhi‐Hao Li
Hua‐Bin Li
Yicheng Xu
Xianglei Kong
Fan Huang
Dong‐Sheng Guo
Jianfeng Liu
author_facet Xiaoxue Hou
Yu‐Xuan Chang
Yu‐Xin Yue
Ze‐Han Wang
Fei Ding
Zhi‐Hao Li
Hua‐Bin Li
Yicheng Xu
Xianglei Kong
Fan Huang
Dong‐Sheng Guo
Jianfeng Liu
author_sort Xiaoxue Hou
collection DOAJ
description Abstract Radiotherapy (RT) has been viewed as one of the most effective and extensively applied curatives in clinical cancer therapy. However, the radioresistance of tumor severely discounts the radiotherapy outcomes. Here, an innovative supramolecular radiotherapy strategy, based on the complexation of a hypoxia‐responsive macrocycle with small‐molecule radiosensitizer, is reported. To exemplify this tactic, a carboxylated azocalix[4]arene (CAC4A) is devised as molecular container to quantitatively package tumor sensitizer banoxantrone dihydrochloride (AQ4N) through reversible host–guest interaction. Benefited from the selective reduction of azo functional groups under hypoxic microenvironment, the supramolecular prodrug CAC4A•AQ4N exhibits high tumor accumulation and efficient cellular internalization, thereby significantly amplifying radiation‐mediated tumor destruction without appreciable systemic toxicity. More importantly, this supramolecular radiotherapy strategy achieves an ultrahigh sensitizer enhancement ratio (SER) value of 2.349, which is the supreme among currently reported noncovalent‐based radiosensitization approach. Further development by applying different radiosensitizing drugs can make this supramolecular strategy become a general platform for boosting therapeutic effect in cancer radiotherapies, tremendously promising for clinical translation.
first_indexed 2024-12-24T03:15:12Z
format Article
id doaj.art-8ac71cb8cd6c470699e6e70e78d81a75
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-12-24T03:15:12Z
publishDate 2022-02-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-8ac71cb8cd6c470699e6e70e78d81a752022-12-21T17:17:40ZengWileyAdvanced Science2198-38442022-02-0196n/an/a10.1002/advs.202104349Supramolecular Radiosensitizer Based on Hypoxia‐Responsive MacrocycleXiaoxue Hou0Yu‐Xuan Chang1Yu‐Xin Yue2Ze‐Han Wang3Fei Ding4Zhi‐Hao Li5Hua‐Bin Li6Yicheng Xu7Xianglei Kong8Fan Huang9Dong‐Sheng Guo10Jianfeng Liu11CAMS Key Laboratory of Radiopharmacokinetics for Innovative Drugs Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin 300192 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCAMS Key Laboratory of Radiopharmacokinetics for Innovative Drugs Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin 300192 P. R. ChinaCollege of Chemistry Key Laboratory of Functional Polymer Materials (Ministry of Education) State Key Laboratory of Elemento‐Organic Chemistry National Demonstration Center for Experimental Chemistry Education Nankai University Tianjin 300071 P. R. ChinaCAMS Key Laboratory of Radiopharmacokinetics for Innovative Drugs Institute of Radiation Medicine Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin 300192 P. R. ChinaAbstract Radiotherapy (RT) has been viewed as one of the most effective and extensively applied curatives in clinical cancer therapy. However, the radioresistance of tumor severely discounts the radiotherapy outcomes. Here, an innovative supramolecular radiotherapy strategy, based on the complexation of a hypoxia‐responsive macrocycle with small‐molecule radiosensitizer, is reported. To exemplify this tactic, a carboxylated azocalix[4]arene (CAC4A) is devised as molecular container to quantitatively package tumor sensitizer banoxantrone dihydrochloride (AQ4N) through reversible host–guest interaction. Benefited from the selective reduction of azo functional groups under hypoxic microenvironment, the supramolecular prodrug CAC4A•AQ4N exhibits high tumor accumulation and efficient cellular internalization, thereby significantly amplifying radiation‐mediated tumor destruction without appreciable systemic toxicity. More importantly, this supramolecular radiotherapy strategy achieves an ultrahigh sensitizer enhancement ratio (SER) value of 2.349, which is the supreme among currently reported noncovalent‐based radiosensitization approach. Further development by applying different radiosensitizing drugs can make this supramolecular strategy become a general platform for boosting therapeutic effect in cancer radiotherapies, tremendously promising for clinical translation.https://doi.org/10.1002/advs.202104349calixarenedrug deliveryradiotherapysupramolecular chemistrytumor hypoxia
spellingShingle Xiaoxue Hou
Yu‐Xuan Chang
Yu‐Xin Yue
Ze‐Han Wang
Fei Ding
Zhi‐Hao Li
Hua‐Bin Li
Yicheng Xu
Xianglei Kong
Fan Huang
Dong‐Sheng Guo
Jianfeng Liu
Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
Advanced Science
calixarene
drug delivery
radiotherapy
supramolecular chemistry
tumor hypoxia
title Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
title_full Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
title_fullStr Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
title_full_unstemmed Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
title_short Supramolecular Radiosensitizer Based on Hypoxia‐Responsive Macrocycle
title_sort supramolecular radiosensitizer based on hypoxia responsive macrocycle
topic calixarene
drug delivery
radiotherapy
supramolecular chemistry
tumor hypoxia
url https://doi.org/10.1002/advs.202104349
work_keys_str_mv AT xiaoxuehou supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT yuxuanchang supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT yuxinyue supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT zehanwang supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT feiding supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT zhihaoli supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT huabinli supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT yichengxu supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT xiangleikong supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT fanhuang supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT dongshengguo supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle
AT jianfengliu supramolecularradiosensitizerbasedonhypoxiaresponsivemacrocycle